The outbreak of the new human coronavirus SARS-CoV-2 (also known as 2019-nCoV) continues to increase globally. The real-time reverse transcription polymerase chain reaction (rRT-PCR) is the most used technique in virus detection. However, possible false-negative and false-positive results produce misleading consequences, making it necessary to improve existing methods. Here, we developed a multiplex rRT-PCR diagnostic method, which targets two viral genes ( RdRP and E ) and one human gene ( RP ) simultaneously. The reaction was tested by using pseudoviral RNA and human target mRNA sequences as a template. Also, the protocol was validated by using 14 clinical SARS-CoV-2 positive samples. The results are in good agreement with the CDC authorized Cepheid`s Xpert ® Xpress SARS-CoV-2 diagnostic system (100%). Unlike single gene targeting strategies, the current method provides the amplification of two viral regions in the same PCR reaction. Therefore, an accurate SARS-CoV-2 diagnostic assay was provided, which allows testing of 91 samples in 96-well plates in per run. Thanks to this strategy, fast, reliable, and easy-to-use rRT-PCR method is obtained to diagnose SARS-CoV-2.
【초록키워드】 SARS-CoV-2, protocol, 2019-nCoV, diagnostic, coronavirus SARS-CoV-2, RNA, Consequences, polymerase chain reaction, amplification, rRT-PCR, Region, Viral, CDC, outbreak, virus detection, RdRP, target, reverse transcription, multiplex, false-negative, diagnose, Diagnostic method, Chain Reaction, Real-Time Reverse Transcription Polymerase Chain Reaction, Template, reaction, sequence, false, positive, viral genes, PCR reaction, single gene, PCR method, 96-well plates, human gene, 96-well plate, target mRNA, polymerase chain, IMPROVE, human coronavirus, provided, provide, viral gene, false-positive result, was tested, 【제목키워드】 SARS-CoV-2, real-time RT-PCR, multiplex, development,